PharMerica Corporation  

(Public, NYSE:PMC)   Watch this stock  
Find more results for PMC
26.57
-0.13 (-0.49%)
After Hours: 26.57 0.00 (0.00%)
Jul 27, 5:00PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 26.41 - 26.91
52 week 19.79 - 36.50
Open 26.83
Vol / Avg. 104,276.00/170,866.00
Mkt cap 825.27M
P/E 27.57
Div/yield     -
EPS 0.96
Shares 30.73M
Beta 0.67
Inst. own 94%
Aug 9, 2016
Q2 2016 PharMerica Corp Earnings Call - 10:00AM EDT - Add to calendar
Aug 9, 2016
Q2 2016 PharMerica Corp Earnings Release - 9:30AM EDT - Add to calendar
Jun 17, 2016
PharMerica Corp Annual Shareholders Meeting (Estimated)
Jun 17, 2016
PharMerica Corp Annual Shareholders Meeting
May 25, 2016
PharMerica Corp at UBS Global Healthcare Conference
May 11, 2016
PharMerica Corp at Bank of America Merrill Lynch Health Care Conference - Webcast
May 6, 2016
Q1 2016 PharMerica Corp Earnings Call - Webcast
May 6, 2016
Q1 2016 PharMerica Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 0.78% 1.73%
Operating margin 1.51% 2.65%
EBITD margin - 6.69%
Return on average assets 1.42% 3.15%
Return on average equity 3.16% 7.04%
Employees 5,800 -
CDP Score - -

Address

1901 Campus Pl
LOUISVILLE, KY 40299-2308
United States - Map
+1-502-6277000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Officers and directors

Geoffrey G. Meyers Independent Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Gregory S. Weishar Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
David W. Froesel Jr. Chief Financial Officer, Executive Vice President, Treasurer
Age: 63
Bio & Compensation  - Reuters
Suresh Vishnubhatla Executive Vice President - Long-term Care Operations
Age: 46
Bio & Compensation  - Reuters
Berard E. Tomassetti Senior Vice President, Chief Accounting Officer
Age: 59
Bio & Compensation  - Reuters
Thomas A. Caneris Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
Age: 52
Bio & Compensation  - Reuters
Mark R. Lindemoen Senior Vice President - Sales and Client Services
Age: 48
Bio & Compensation  - Reuters
Robert A. McKay Senior Vice President - Purchasing and Trade Relations
Age: 53
Bio & Compensation  - Reuters
Frank E. Collins Esq. Independent Director
Age: 61
Bio & Compensation  - Reuters
W. Robert Robert Dahl Jr Independent Director
Age: 57
Bio & Compensation  - Reuters